Pharma Deals Review, Vol 2010, No 9 (2010)

Font Size:  Small  Medium  Large

UCB Buys Rights to Two Parkinson’s Disease Therapies from Synosia Therapeutics

Editorial Team

Abstract


UCB SA has acquired rights to two promising treatments for Parkinson’s disease from Synosia Therapeutics for an equity investment of USD 20 M and other payments which touch USD 725 M.



Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.